UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis

Journal of allergy and clinical immunology, 2007-06, Vol.119 (6), p.1550-1551

2007

Volltextzugriff (PDF)

Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2019-04, Vol.7 (4), p.1314-1316

2019

Volltextzugriff (PDF)

Tirzepatide Once Weekly for the Treatment of Obesity

The New England journal of medicine, 2022-07, Vol.387 (3), p.205-216

2022

Volltextzugriff (PDF)

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2015-08, Vol.314 (7), p.687

2015

Volltextzugriff (PDF)

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2024-01, Vol.331 (1), p.38

2024

Volltextzugriff (PDF)

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

The Lancet (British edition), 2012-04, Vol.379 (9825), p.1489-1497

2012

Volltextzugriff (PDF)

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

The journal of clinical endocrinology and metabolism, 2013-03, Vol.98 (3), p.1154-1162

2013

Volltextzugriff (PDF)

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1293

2013

Volltextzugriff (PDF)

Regulation of the HIV Promoter/Enhancer

Current Protocols in Immunology, 2003-05, Vol.54 (1), p.12.7.1-12.7.18

2003

Volltextzugriff (PDF)

Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection

The Journal of clinical investigation, 1999-02, Vol.103 (4), p.453-460

1999

Volltextzugriff (PDF)

Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals

Metabolism, clinical and experimental, 2002-09, Vol.51 (9), p.1111-1119

2002

Volltextzugriff (PDF)

Tumor Necrosis Factor α Functions in an Autocrine Manner in the Induction of Human Immunodeficiency Virus Expression

Proceedings of the National Academy of Sciences - PNAS, 1990-01, Vol.87 (2), p.782-785

1990

Volltextzugriff (PDF)

Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms

The Journal of experimental medicine, 1990-07, Vol.172 (1), p.151-158

1990

Volltextzugriff (PDF)

Activation of the serum response factor by p65/NF- Kappa B

The EMBO journal, 1996-07, Vol.15 (13), p.3403-3412

1996

Volltextzugriff (PDF)

Vascular smooth muscle cells express a constitutive NF-kappa B-like activity

The Journal of biological chemistry, 1994-11, Vol.269 (46), p.28913-28918

1994

Volltextzugriff (PDF)

Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism

Molecular medicine (Cambridge, Mass.), 2001-10, Vol.7 (10), p.668-678

2001

Volltextzugriff (PDF)

Interferon γ induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells

The Journal of experimental medicine, 1992-09, Vol.176 (3), p.739-750

1992

Volltextzugriff (PDF)

Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage

The Journal of experimental medicine, 1991-03, Vol.173 (3), p.589-597

1991

Volltextzugriff (PDF)

DIAGNOSIS AND TREATMENT OF THE SYSTEMIC AND CUTANEOUS NECROTIZING VASCULITIS SYNDROMES

The Medical clinics of North America, 1997, Vol.81 (1), p.243-259

1997

Volltextzugriff (PDF)

Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection

The Journal of clinical investigation, 1999-03, Vol.103 (6), p.921-921

1999

Volltextzugriff (PDF)

Retinoic Acid Mimics Transforming Growth Factor β in the Regulation of Human Immunodeficiency Virus Expression in Monocytic Cells

Proceedings of the National Academy of Sciences - PNAS, 1992-04, Vol.89 (7), p.2689-2693

1992

Volltextzugriff (PDF)

Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants

Journal of Virology, 1993-01, Vol.67 (1), p.288-293

1993

Volltextzugriff (PDF)

Acute cardiac and pulmonary arrest after infusion of vancomycin with subsequent desensitization

Journal of allergy and clinical immunology, 1997-12, Vol.100 (6), p.853-854

1997

Volltextzugriff (PDF)

Heat shock induction of HIV production from chronically infected promonocytic and T cell lines

The Journal of immunology (1950), 1990-08, Vol.145 (4), p.1120-1126

1990

Volltextzugriff (PDF)

Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment

Journal of lipid mediators and cell signalling, 1997-11, Vol.17 (2), p.97-113

1997

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(144)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(178)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(88)
Humans
(74)
Female
(37)
Male
(36)
Biological And Medical Sciences
(31)
Middle Aged
(24)
Adult
(21)
Medical Sciences
(20)
Ophthalmology
(19)
Gastroenterology & Hepatology
(18)
Aged
(17)
Animals
(15)
Technology
(13)
Fundamental And Applied Biological Sciences. Psychology
(12)
Aids/hiv
(11)
Gastroenterology And Hepatology
(11)
Physical Sciences
(11)
Treatment Outcome
(11)
Cell Line
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis

Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis

Tirzepatide Once Weekly for the Treatment of Obesity

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Regulation of the HIV Promoter/Enhancer

Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection

Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals

Tumor Necrosis Factor α Functions in an Autocrine Manner in the Induction of Human Immunodeficiency Virus Expression

Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms

Activation of the serum response factor by p65/NF- Kappa B

Vascular smooth muscle cells express a constitutive NF-kappa B-like activity

Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism

Interferon γ induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells

Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage

DIAGNOSIS AND TREATMENT OF THE SYSTEMIC AND CUTANEOUS NECROTIZING VASCULITIS SYNDROMES

Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection

Retinoic Acid Mimics Transforming Growth Factor β in the Regulation of Human Immunodeficiency Virus Expression in Monocytic Cells

Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants

Acute cardiac and pulmonary arrest after infusion of vancomycin with subsequent desensitization

Heat shock induction of HIV production from chronically infected promonocytic and T cell lines

Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment

Suchergebnisse filtern